Seeking Alpha

Merck (MRK) CEO Kenneth Frazier jostles for positioning in the fiscal cliff debate, warning that...

Merck (MRK) CEO Kenneth Frazier jostles for positioning in the fiscal cliff debate, warning that proposals to put "additional price controls on drugs" could "take away much of the incentive in the capital markets to invest in research and development." The Democrats have proposed reducing soaring medical costs by using Medicare to negotiate lower drug prices.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector